The recent acquisitions of Ergomed and Instem underscore an emerging trend: private equity entities seeking out undervalued UK life sciences firms that have been constrained by AIM’s insufficient capital resources.
The recent acquisitions of Ergomed and Instem underscore an emerging trend: private equity entities seeking out undervalued UK life sciences firms that have been constrained by AIM’s insufficient capital resources.
On the face of it, Changeangel.io’s business model is pretty straightforward. It facilitates crypto to crypto, wallet to wallet swaps. Yet, there is something much bigger afoot at the company
On the face of it, Changeangel.io’s business model is pretty straightforward. It facilitates crypto to crypto, wallet to wallet swaps. Yet, there is something much bigger afoot at the company